Holding a subspecialty webinar on multiple myeloma management and COVID-19 on May 21st with the presence of prominent professors of medical oncology from Tehran, Dr. Mousavi, Dr. Razavi, Dr. Shahi, from Rasht, Dr. Najafi, from Isfahan, Dr. Ashrafi, simultaneously with the unveiling Bortezomib Acte was administered.
This webinar talked about how to manage the treatment of patients with multiple myeloma in the epidemic of COVID-19.